Mitochondria are dynamic organelles, undergoing both fission and fusion regularly in interphase cells. Mitochondrial fission is thought to be part of a quality-control mechanism whereby damaged mitochondrial components are segregated from healthy components in an individual mitochondrion, followed by mitochondrial fission and degradation of the damaged daughter mitochondrion [1] . Fission also plays a role in apoptosis [2] . Defects in mitochondrial dynamics can lead to neurodegenerative diseases such as Alzheimer's disease [3] . Mitochondrial fission requires the dynamin GTPase Drp1, which assembles in a ring around the mitochondrion and appears to constrict both outer and inner mitochondrial membranes [4] . However, mechanisms controlling Drp1 assembly on mammalian mitochondria are unclear. Recent results show that actin polymerization, driven by the endoplasmic reticulum-bound formin protein INF2, stimulates Drp1 assembly at fission sites [5] . Here, we show that myosin II also plays a role in fission. Chemical inhibition by blebbistatin or small interfering RNA (siRNA)-mediated suppression of myosin IIA or myosin IIB causes an increase in mitochondrial length in both control cells and cells expressing constitutively active INF2. Active myosin II accumulates in puncta on mitochondria in an actinand INF2-dependent manner. In addition, myosin II inhibition decreases Drp1 association with mitochondria. Based on these results, we propose a mechanistic model in which INF2-mediated actin polymerization leads to myosin II recruitment and constriction at the fission site, enhancing subsequent Drp1 accumulation and fission.
Summary
Mitochondria are dynamic organelles, undergoing both fission and fusion regularly in interphase cells. Mitochondrial fission is thought to be part of a quality-control mechanism whereby damaged mitochondrial components are segregated from healthy components in an individual mitochondrion, followed by mitochondrial fission and degradation of the damaged daughter mitochondrion [1] . Fission also plays a role in apoptosis [2] . Defects in mitochondrial dynamics can lead to neurodegenerative diseases such as Alzheimer's disease [3] . Mitochondrial fission requires the dynamin GTPase Drp1, which assembles in a ring around the mitochondrion and appears to constrict both outer and inner mitochondrial membranes [4] . However, mechanisms controlling Drp1 assembly on mammalian mitochondria are unclear. Recent results show that actin polymerization, driven by the endoplasmic reticulum-bound formin protein INF2, stimulates Drp1 assembly at fission sites [5] . Here, we show that myosin II also plays a role in fission. Chemical inhibition by blebbistatin or small interfering RNA (siRNA)-mediated suppression of myosin IIA or myosin IIB causes an increase in mitochondrial length in both control cells and cells expressing constitutively active INF2. Active myosin II accumulates in puncta on mitochondria in an actinand INF2-dependent manner. In addition, myosin II inhibition decreases Drp1 association with mitochondria. Based on these results, we propose a mechanistic model in which INF2-mediated actin polymerization leads to myosin II recruitment and constriction at the fission site, enhancing subsequent Drp1 accumulation and fission.
Results and Discussion
While Drp1 clearly is essential for mitochondrial fission, several studies have suggested that an initial Drp1-independent constriction step might be required prior to Drp1 accumulation [6] [7] [8] . In a previous publication, we presented data showing that actin polymerization at this site, initiated by INF2 on the endoplasmic reticulum (ER) membrane, provided the force to drive this initial constriction, with the pointed ends of these actin filaments pushing the mitochondrial outer membrane inward [5] . This model bears some resemblance to other polymerization-based force generation events, such as leading-edge extension in cell motility or the initial steps of endocytosis [9] . Another actin-based mechanism for force generation, however, is the use of myosin II to constrict antiparallel actin filament networks [10] , such as in muscle contraction, stress fiber contraction [11] , and possibly cytokinesis [12] . Indeed, recent results suggest a role for myosins in mammalian mitochondrial fission, as suppression of myosin regulatory light chain or inhibition of myosin light-chain kinase causes increases in mitochondrial length [13] . Here, we address the role of myosin II in this process and its relationship to INF2 and Drp1.
Myosin II Inhibition Increases Mitochondrial Length
As an initial test of myosin II involvement in mitochondrial dynamics, we used the small-molecule myosin II inhibitor blebbistatin [14] on U2OS human osteosarcoma cells and measured lengths of peripheral mitochondria. Short-term blebbistatin treatment results in decreased stress fiber density (see Figure S1A available online) and a significant increase in mean mitochondrial length from 5.29 to 6.77, 8.28, and 7.57 mm at 30, 60, and 120 min, respectively ( Figure 1 ). This is likely an underestimate of mitochondrial length change, because many of the mitochondria become too long to measure after blebbistatin treatment, with one extremity being obscured in the perinuclear region. Even so, analysis of the histogram of mitochondrial lengths shows a significant increase in the longest mitochondria upon blebbistatin treatment, with the percentage of mitochondria > 10 mm increasing from 13.6 to 29.2, 43.2, and 40.3 at the three time points tested ( Figure S1B ). Interestingly, inhibition of Arp2/3 complex with the small-molecule inhibitor CK666 does not affect mitochondrial length ( Figure 1C ), despite its potent inhibition of lamellipodia under these conditions ( Figures S1C and S1D ). This result is significant, because it suggests that INF2 is acting in an Arp2/3-independent manner in producing the actin filaments that serve in mitochondrial fission, making the process different from others in which formins act in concert with Arp2/3 complex [15] .
We have previously shown that the constitutively active A149D mutant of INF2-CAAX (INF2-A149D) causes a significant mitochondrial length decrease and enriches at fission sites [5] . To test whether myosin II inhibition reverses this effect, we treated INF2-A149D-transfected U2OS cells with blebbistatin and measured peripheral mitochondrial length. As observed previously, INF2-A149D expression decreases mitochondrial length by >2-fold ( Figure 1B) . Blebbistatin treatment partially reverses this effect, with mitochondrial lengths of 2.18, 3.87, 4.42, and 4.49 mm at 0, 30, 60, and 120 min, respectively ( Figures 1A and 1B) . The percentage of mitochondria > 10 mm increases from 0% (INF2-A149D alone) to 7.3%, 10.1%, and 11.8% for 30, 60, and 120 min, respectively.
While blebbistatin displays specificity for myosin II over three other myosin classes (I, V, and X) [14] , most of the 20+ classes of mammalian myosins have not been tested for blebbistatin sensitivity, raising the question of whether myosin II is the target for blebbistatin's effect on mitochondrial length. For this reason, we also used an RNAi approach to suppress expression of the two predominant nonmuscle myosin II proteins, IIA and IIB, in U2OS cells. Treatment with specific small interfering RNA (siRNA) oligonucleotides results in a >80% reduction in the targeted myosin II, with no significant effect on levels of the other myosin II or on two other myosins ( Figure S2 ).
Suppression of either myosin IIA (MIIA) or myosin IIB (MIIB) results in a significant increase in mitochondrial length, from 5.21 mm to 9.46 and 9.15 mm for IIA or IIB, respectively *Correspondence: henry.higgs@dartmouth.edu ( Figures 2A and 2C ). In addition, suppression of MIIA or MIIB partially reverses the effect of INF2-A149D expression in U2OS cells ( Figures 2B and 2D ), increasing average length by 37% and 31%, respectively. Interestingly, combined suppression of MIIA and MIIB does not cause an additive increase in mitochondrial length above that caused by suppression of either myosin individually ( Figures 2B and 2D ). However, limitations in measuring long mitochondria, described above, might hinder detection of such length changes. These results suggest that myosin II plays a role in mitochondrial fission, possibly utilizing the actin filaments generated by INF2.
Localization of Myosin II to Fission Sites
We next asked whether myosin II enriched at mitochondrial fission sites, initially conducting immunofluorescence localization of endogenous protein. One issue with analyzing myosin II localization is protein abundance, which causes extensive staining throughout the cell and is particularly intense on stress fibers. In this respect, we found that an antibody against serine 19-phosphorylated (activated) myosin light chain (anti-P-MRLC) gave the lowest background staining and thus was most suitable for examining mitochondrial localization against a high background of stress fibers. Anti-P-MRLC staining was detected at sites of mitochondrial constriction ( Figures 3A and 3B ). In cells costained for P-MRLC, mitochondria, and ER, P-MRLC accumulated at constriction sites also enriched for ER ( Figure 3A) .
We also examined myosin II localization to mitochondria in live cells, using a GFP fusion of MIIA expressed on a lowexpressing ''speckle'' promoter, since low expression was found to be important in limiting artifactual myosin II-containing structures in previous studies [16] . Despite the confounding influence of extensive accumulation on stress fibers, GFP-MIIA accumulates transiently at mitochondrial constriction sites undergoing fission ( Figure 3C ; Movie S1).
In another strategy to examine myosin II enrichment on mitochondria, we used confocal microscopy to examine more apical regions, avoiding the ventral surface that contains a high density of actomyosin-based structures. The perinuclear region contains abundant mitochondria and is relatively devoid of stress fibers. Though their lengths are difficult to quantify due to their high density in this location, these mitochondria appear generally shorter than peripheral mitochondria, similar to observations made in other cells [17] .
Anti-P-MRLC puncta enrich on these mitochondria ( Figures  3D and S3A ). Both actin depolymerization by latrunculin B treatment and INF2 inhibition by siRNA cause significant decreases in the number of these puncta ( Figures 3D and S3B ). Taken together, these results suggest that INF2-assembled actin filaments are required for active myosin II association with mitochondria.
Myosin II Inhibition Results in Decreased Mitochondrially Associated Drp1
We have previously shown that INF2 suppression results in decreased mitochondrially associated Drp1, suggesting that INF2 acts upstream of Drp1 [5] . To test whether myosin II acts at a similar stage in the process, we examined Drp1 distribution after myosin II suppression. In control cells, Drp1 accumulated as puncta on the mitochondrial surface ( Figure 4A ). Suppression of either MIIA or MIIB significantly reduced the number of mitochondrially associated Drp1 puncta (Figure 4) . Previous results have shown that myosin regulatory light chain (MRLC) inhibition, either by siRNA suppression or by a myosin light chain kinase (MLCK) inhibitor, increases mitochondrial length and decreases mitochondrially associated Drp1 puncta [13] . Since MRLC interacts with several classes of myosin [18] (J. Sellers, personal communication), it was not clear which myosin was the relevant motor. Our work shows that myosin II specifically plays a role in this process.
Based on these results, we propose an alternative to our previous actin polymerization-based model for initial mitochondrial constriction ( Figure S4 ). INF2 activation at the ERmitochondrial interface results in actin filament assembly. These filaments assume mixed orientations around the mitochondrion. Myosin II minifilaments are recruited to these actin filaments, and their motor activity results in contraction of the actin filament network either parallel or perpendicular to the fission plane, constricting the mitochondrion. This initial constriction allows Drp1 to bind and oligomerize at the constriction site. A preconstriction event has been suggested by previous findings [6] [7] [8] . Another possibility is that actin and/or myosin II might help recruit Drp1 to the fission site by direct binding, perhaps in conjunction with one of the outer mitochondrial membrane proteins purported to act as a Drp1 receptor [19, 20] . Such binding has been suggested by cellular experiments [13] and is consistent with direct binding between dynamin and actin filaments [21] . The myosin II might be recruited from another structure. We do not think that this structure would consist of existing dorsal or ventral stress fibers, since serum starvation in Dulbecco's modified Eagle's medium (DMEM), which strongly reduces these structures, actually causes mitochondria to become shorter (data not shown), and since previous reports failed to detect any association between mitochondria and stress fibers [22] . Still, other myosin II-based structures, such as cortical actomyosin [23] , might contribute.
There are parallels between this model and assembly of other contractile bundles requiring both a formin and myosin II, such as cytokinetic ring assembly [12, 24] . Based on these similarities, we refer to the process of INF2-and myosin II-mediated mitochondrial constriction as ''mitokinesis.'' It is possible that myosin II is required not for mitochondrial constriction per se but for organization and stabilization of the ring structure, similar to some models of cytokinesis [25] [26] [27] . One clear difference between this process and cytokinesis is that myosin recruitment to mitochondria depends on actin filaments and formin, whereas myosin II is recruited to the site of cytokinesis independently of actin where tested [28] [29] [30] .
It might seem curious that both MIIA and MIIB appear to play roles in mitochondrial fission, but a series of studies shows that the two myosins also play complementary roles in actomyosin fiber assembly during fibroblast polarization [16] . MIIA is the more dynamic protein, assembling into short actomyosin structures early in polarization, whereas MIIB stabilizes these structures at later time points. Studies with genetically modified mice suggest that MIIA can replace some but not all physiological functions of MIIB [31] . Thus, it is possible that MIIA and MIIB play partially redundant roles also in mitochondrial fission, perhaps forming hetero-oligomers within the same minifilament. Alternately, it is possible that there are separate pools of MIIA-and MIIB-dependent fission events, but this seems less likely, particularly because simultaneous suppression of both proteins does not result in measurably longer mitochondria.
However, it is worth remembering that mitochondrial populations are heterogeneous, both within individual cell types and between cell types [17] . There might also be multiple mechanisms for inducing mitochondrial fission, although all are likely to go through Drp1 ultimately. Our results suggest that myosin II and INF2 act in the same fission mechanism, but we do not discount the fact that other mechanisms independent of myosin II, INF2, and actin might also exist for this important process.
Finally, we do not rule out other configurations of actin filaments and myosin that might produce similar constrictive forces. One issue that might compromise a cytokinetic-like actomyosin ring during mitochondrial fission is that the purified nonmuscle myosin II minifilament has been measured at between 230 and 320 nm in length [32] [33] [34] , about the same size as the width of a mammalian mitochondrion. However, considerably smaller myosin II oligomers appear to exist in cells [35] . Myosin II involvement in mitochondrial fission is the latest in a growing relationship between myosins and mitochondrial dynamics in general. Myosin V is required for proper mitochondrial distribution in budding yeast, although there is vigorous debate as to whether this myosin acts to transport mitochondria along actin cables [36] or acts as a mitochondrial retention factor [37] . Interestingly, myosin V depletion actually stimulates axonal mitochondrial motility (both anterograde and retrograde) in Drosophila neurons, whereas myosin VI depletion stimulates only retrograde motility [38] . In the same system, myosin V depletion (but not that of myosin VI or myosin II) increases mitochondrial length, possibly suggesting a role for myosin V in mitochondrial fission in axonal mitochondria. Another widely expressed myosin, myosin 19, enriches strongly on mitochondria and acts in mitochondrial motility in cultured cells, although there is no evidence that it acts in mitochondrial fission [39] . Finally, myosin II has been implicated in maintenance of the mitochondrial genome, with the suggestion that both actin and myosin II might be present in the mitochondrial matrix [40] .
The examples described above highlight the potential for multiple mechanisms controlling mitochondrial dynamics. For example, the effects of myosin V on mitochondrial size in Drosophila axons [38] might reflect a fundamentally different Figure S3 for quantification of mitochondria-associated P-MRLC puncta in these treatments, as well as close-up images of apical mitochondria, P-MRLC, and actin filaments.
fission mechanism than that observed in this paper. The possibility of multiple mechanisms will be useful to keep in mind in the continued elucidation of fission pathways.
Experimental Procedures
Plasmids and siRNA Oligonucleotides The human full-length GFP-INF2 CAAX A149D construct was described previously [5] . The ER-green construct, containing the ER-targeting sequence (amino acids 233-250) of budding yeast UBC6 [41] , was a gift from Victoria Allan (University of Manchester). Further details are provided in Supplemental Experimental Procedures.
Cell Culture, Transfections, and Drug Treatment U2OS cell lines were grown in DMEM (Invitrogen) supplemented with 10% calf serum (Atlanta Biologicals). Plasmid transfections were performed in Opti-MEM media (Invitrogen) with Lipofectamine 2000 (Invitrogen). siRNA transfections used RNAmax (Invitrogen). Cells were analyzed 24 hr and 72-80 hr posttransfection for DNA and RNAi, respectively. Cells were treated with MitoTracker Red CMXRos (Invitrogen) at 100 nM in DMEM 20 min prior to fixation. Chemical inhibitor treatments were 50 mM blebbistatin (Sigma-Aldrich), 200 mM CK666 or CK689 (Calbiochem), or 0.5 mM latrunculin B (Calbiochem). Further details are provided in Supplemental Experimental Procedures.
Antibodies
Antibodies against nonmuscle MIIA, MIIB, P-MRLC, and Drp1 were from Cell Signaling. Monoclonal anti-tubulin DM1-a was from Sigma. Secondary antibodies used were Texas red, Cy5, or fluorescein-conjugated anti-rabbit immunoglobulin G (Jackson ImmunoResearch Laboratories and Vector Laboratories, respectively). Further details are provided in Supplemental Experimental Procedures.
Immunofluorescence Microscopy Cells were fixed with 4% formaldehyde (Electron Microscopy Sciences) in PBS for 30 min at room temperature prior to primary and secondary antibody treatment. When needed, Alexa Fluor 450-phalloidin (Invitrogen), TRITC-phalloidin (Sigma-Aldrich), and/or DAPI were added to the secondary antibody solution. Samples were mounted on polyvinyl alcohol-DABCO. Further details are provided in Supplemental Experimental Procedures.
Live Imaging and Confocal Microscopy
Imaging of live and fixed cells was performed using a temperaturecontrolled spinning-disk confocal system from Quorum Technologies on a Nikon Eclipse Ti microscope. Images and movies were processed using Nikon Elements and Adobe Photoshop CS. Further details are provided in Supplemental Experimental Procedures.
Measurements and Image Analysis
To measure mitochondrial length, we created maximum-intensity projections of z series with 0.2 mm increments for the red channel (MitoTracker or mito-dsRed). The flat regions of cells with clearly resolved mitochondria were selected, and 25-30 mitochondria per cell were measured using the line tool in Nikon Elements software. Drp1 puncta were counted on fixed cells labeled with anti-Drp1 antibody. To assess P-MRLC localization at sites of apical mitochondria, we chose a representative confocal slice at least 1.4 mm from the ventral surface and made a 5 3 5 mm box within the region containing apical mitochondria. The number of P-MRLC puncta within this box was counted manually, with a positive punctum defined as a region < 5 pixels in either dimension whose intensity was clearly above background. Statistical analysis was performed in Microsoft Excel; data are presented as mean 6 SE from at least two experiments. Unpaired Student's t tests were used to compare values, with p < 0.01 considered significant. Further details are provided in Supplemental Experimental Procedures.
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